Vincent Milano's Net Worth
$37.3 Million
Who is Vincent Milano?
Vincent Milano has an estimated net worth of $37.3 Million. This is based on reported shares across multiple companies, which include Aclaris Therapeutics, Inc., Vanda Pharmaceuticals Inc., BIOCRYST PHARMACEUTICALS INC, Spark Therapeutics, Inc., Aceragen, Inc., VIROPHARMA INC, and VERTICALNET INC.
SEC CIK
Vincent Milano's CIK is 0001187159
Past Insider Trading and Trends
2007 was Vincent Milano's most active year for acquiring shares with 16 total transactions. Vincent Milano's most active month to acquire stocks was the month of May. 2014 was Vincent Milano's most active year for disposing of shares, totalling 21 transactions. Vincent Milano's most active month to dispose stocks was the month of November. 2013 saw Vincent Milano paying a total of $6,317,884.63 for 728,029 shares, this is the most they've acquired in one year. In 2014 Vincent Milano cashed out on 1,433,398 shares for a total of $24,114,050.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aclaris Therapeutics, Inc. (ACRS) Snapshot price: $1.11
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| +59.26% | 4.66K |
—
|
—
| 12.52K |
Jun 1
| |||
Form 4
| +134.30% | 4.51K |
—
|
—
| 7.86K |
Jun 1 - Jun 2
| |||
Form 4
|
∞
| 3.36K |
—
|
—
| 3.36K |
Jun 2 - Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vanda Pharmaceuticals Inc. (VNDA) Snapshot price: $3.625
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +100.00% | 5K |
—
|
—
| 10K |
Jun 13
| |||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOCRYST PHARMACEUTICALS INC (BCRX) Snapshot price: $5.305
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.05% | 6.82K |
—
|
—
| 74.69K |
Jun 12
| |||
Form 4
| +1.30% | 870 |
$6.46 | $5,620.20 | 67.87K |
May 31
| |||
Form 4
| +28.85% | 15K |
$6.25 | $93,750.00 | 67K |
May 20
| |||
Form 4
| +1.96% | 1K |
$5.63 | $5,624.37 | 52K |
Feb 29
| |||
Form 4
| +1.91% | 956 |
$5.88 | $5,621.28 | 51K |
Nov 30
| |||
Form 4
| +1.61% | 791 |
$7.11 | $5,624.01 | 50.04K |
Aug 31
| |||
Form 4
| +51.51% | 16.75K |
—
|
—
| 49.25K |
Jun 13
| |||
Form 4
| +2.14% | 680 |
$8.27 | $5,623.60 | 32.51K |
May 31
| |||
Form 4
| +2.04% | 635 |
$8.85 | $5,619.75 | 31.83K |
Feb 28
| |||
Form 4
| +1.37% | 421 |
$13.36 | $5,624.56 | 31.19K |
Nov 30
| |||
Form 4
| +1.33% | 404 |
$13.90 | $5,615.60 | 30.77K |
Aug 31
| |||
Form 4
| +73.52% | 12.87K |
—
|
—
| 30.37K |
Jun 7
| |||
Form 4
| +75.00% | 7.5K |
$12.19 | $91,425.00 | 17.5K |
Nov 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Spark Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.00K |
$114.50 | -$343,500.00 |
0
|
Dec 17
| |||
Form 4
| +100.00% | 1.5K |
—
|
—
| 3K |
May 30
| |||
Form 4
|
∞
| 1.5K |
—
|
—
| 1.5K |
May 30 - May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aceragen, Inc. No price found
PRESIDENT AND CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -26.76% | -3.28K |
$0.53 | -$1,750.17 | 8.99K |
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 6
| |||
Form 4/A
| -3.36% | -3.01K |
$1.78 | -$5,351.88 | 86.56K |
Scheduled
|
Jan 7
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +19.37% | 40K |
$1.97 | $78,800.00 | 246.53K |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
∞
| 200K |
$4.00 | $799,100.00 | 200K |
Dec 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||